, /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Cepton, Inc. (NASDAQ: CPTN) ("Cepton" or the "Company") on behalf of investors who purchased or sold Cepton shares during the period of July 29, 2024 through January 6, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or sold Cepton securities during the Class Period may, no later than December 8, 2025, seek to be appointed as a lead plaintiff representative of the class. To l ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Snap Inc. securities between April 29, 2025, and August 5, 2025, of the upcoming lead plaintiff deadline on October 20, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Snap securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by October 20, 2025 [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in this area [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in terms of settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing their capability in recovering funds for clients [4]. Group 3: Case Allegations - The lawsuit alleges that Snap's management misled investors by presenting overly optimistic projections regarding advertising revenue and growth, while downplaying existing execution issues [5]. - It is claimed that when the true situation was revealed, investors suffered damages due to the discrepancies between reported expectations and actual performance [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][3]. Group 1: Class Action Details - Investors who bought Semler Scientific securities between March 10, 2021, and April 15, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file a motion by October 28, 2025 [3]. - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [4]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [4].

Core Viewpoint - A class action lawsuit has been filed against KBR, Inc. for allegedly making false and misleading statements regarding its partnership with HomeSafe, which led to a significant drop in KBR's stock price after the termination of a contract by the U.S. Department of Defense's TRANSCOM [1][3][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired KBR shares between May 6, 2025, and June 19, 2025 [1][2]. - Investors have until November 18, 2025, to seek appointment as lead plaintiff representatives [2]. - The allegations include KBR's failure to disclose concerns from TRANSCOM about HomeSafe's ability to fulfill its obligations under the Global Household Goods Contract [3]. Group 2: Impact on Stock Price - Following the announcement of the contract termination by HomeSafe on June 19, 2025, KBR's shares fell by $3.85, or 7%, closing at $48.93 on June 20, 2025 [4]. Group 3: Company Background - KBR, Inc. is headquartered in Houston, Texas, and provides engineering, logistics, defense contracting, and mission-critical government services [2].

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation (FLR) by Berger Montague on behalf of investors who acquired shares between February 18, 2025, and July 31, 2025, due to alleged misrepresentation of the company's financial condition and undisclosed issues with major infrastructure projects [1][3]. Company Overview - Fluor Corporation, headquartered in Irving, Texas, provides engineering, procurement, construction, and project management services globally, with its Urban Solutions segment being the largest revenue contributor [2]. Allegations and Investigation - The investigation focuses on claims that FLR misrepresented its financial health and concealed rising costs and delays in key infrastructure projects, specifically the Gordie Howe, I-635/LBJ, and I-35 projects, which are vital to its Urban Solutions segment [3]. Financial Performance - On August 1, 2025, FLR reported disappointing Q2 2025 results, with earnings per share (EPS) of $0.43 and revenue of $3.98 billion, missing consensus estimates by $0.13 and $570 million, respectively. The company also reduced its full-year forecast, attributing the shortfall to project execution failures and a slowdown in new contract awards. Following this announcement, FLR's stock price fell over 27%, closing at $41.42 on the same day [4]. Market Reaction - In the wake of the disappointing results, several brokerages downgraded FLR's stock, citing significant concerns regarding the company's internal controls and transparency [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Snap Inc. securities between April 29, 2025, and August 5, 2025, of the upcoming lead plaintiff deadline on October 20, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Snap securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 20, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Background - The lawsuit alleges that Snap's management misled investors by presenting an overly optimistic view of the company's advertising revenue and growth potential while downplaying significant execution errors [5]. - The lawsuit claims that when the true situation regarding Snap's performance became known, investors suffered damages due to the misleading information provided during the Class Period [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fiserv, Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Fiserv common stock purchase is from July 24, 2024, to July 22, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by September 22, 2025, to serve as lead plaintiff [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3]. Group 3: Case Allegations - The lawsuit alleges that Fiserv made false and misleading statements regarding its Clover platform, which was forced upon Payeezy merchants due to issues with the older Payeezy platform [4]. - It is claimed that Clover's revenue growth was artificially inflated by these forced migrations, masking a slowdown in new merchant business [4]. - The lawsuit further alleges that many former Payeezy merchants switched to competitors due to Clover's high pricing and compatibility issues, leading to a significant slowdown in Clover's growth metrics [4].

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified Class Period [1][2]. Company Overview - RxSight, Inc. is a medical technology company based in Aliso Viejo, CA, specializing in light adjustable intraocular lenses (LAL) used in cataract surgery, with its system involving the Light Delivery Device (LDD) [2]. Legal Allegations - The lawsuit alleges that RxSight's management failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. The CEO attributed the sales stall to adoption challenges [4]. - Following this announcement, RxSight's shares dropped by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased iRobot Corporation securities during the specified Class Period of the upcoming lead plaintiff deadline on September 5, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought iRobot securities between January 29, 2024, and March 11, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by the September 5, 2025 deadline [2]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in this area [3]. - The firm has achieved significant settlements, including over $438 million for investors in 2019, and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Case Allegations - The lawsuit alleges that iRobot made false and misleading statements regarding its Restructuring Plan and its ability to operate profitably as a standalone company after the termination of the Amazon Acquisition [4]. - It is claimed that there was substantial doubt about iRobot's ability to continue as a going concern, and that the defendants' public statements were materially false and misleading throughout the Class Period [4].

Core Viewpoint - Berger Montague PC is investigating claims against CTO Realty Growth, Inc. for allegedly misleading investors regarding its financial condition and manipulating key metrics [1][2] Group 1: Legal Investigation - The investigation pertains to claims under federal securities laws against CTO Realty Growth, a real estate investment trust based in Winter Park, Florida [1] - Investors who acquired CTO securities between February 18, 2021, and June 24, 2025, have until October 7, 2025, to seek appointment as lead plaintiff [2] Group 2: Allegations and Financial Misconduct - The lawsuit alleges that CTO misled investors by overstating the profitability of properties, including Ashford Lane in Atlanta [2] - A report by Wolfpack Research accused CTO of covering a $38 million dividend shortfall by diluting shareholders, increasing the outstanding share count by 70% [3] - The report also claimed CTO used a "sham loan" to conceal issues with a collapsed tenant at Ashford Lane [3] Group 3: Market Reaction - Following the allegations, CTO's stock experienced a 5.42% decline, closing at $17.10 per share on June 25, 2025 [3]